Search results for “CISH” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 72 patents, we discovered top 15 key players by total patent application. Sangamo Therapeutics, Inc., Editas Medicine, Inc., Ventana Medical Systems, Inc. are dominant in this area. They take 51.39% of the total patent filing.
Sangamo Therapeutics, Inc.
California, United States
Patent: 20
Editas Medicine, Inc.
Massachusetts, United States
Patent: 9
Ventana Medical Systems, Inc.
Arizona, United States
Patent: 8
Intima Bioscience, Inc.
New York, United States
Patent: 7
InVivo BioTech Services GmbH
Brandenburg, Germany
Patent: 7
Life Technologies Corp.
California, United States
Patent: 5
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 5
Zymed Laboratories, Inc.
California, United States
Patent: 3
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 2
Cellectis SA
France
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 59 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Sangamo Therapeutics, Inc., The Board of Regents of The University of Texas System, Editas Medicine, Inc. take 67.80% of patent filing during this period.
Sangamo Therapeutics, Inc.
California, United States
Patent: 20
The Board of Regents of The University of Texas System
Texas, United States
Patent: 11
Editas Medicine, Inc.
Massachusetts, United States
Patent: 9
Regents of the University of California
California, United States
Patent: 6
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 5
University of Minnesota
Minnesota, United States
Patent: 2
Department of Health & Human Services
Australia
Patent: 2
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 2
Intima Bioscience, Inc.
New York, United States
Patent: 2
Cellectis SA
France
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 59 patents in last 5 years, we discover 10 new entrants. Sangamo Therapeutics, Inc., The Board of Regents of The University of Texas System, Editas Medicine, Inc. are the most active new entrants in this area.
Sangamo Therapeutics, Inc.
California, United States
Patent: 20
The Board of Regents of The University of Texas System
Texas, United States
Patent: 11
Editas Medicine, Inc.
Massachusetts, United States
Patent: 9
Regents of the University of California
California, United States
Patent: 6
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 5
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 2
Cellectis SA
France
Patent: 2
The Walter & Eliza Hall Institute of Medical Research
New South Wales, Australia
Patent: 1
Board of Regents of the New Mexico University
New Mexico, United States
Patent: 1
ONK Therapeutics Ltd.
GALWAY, Ireland
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 27 patents, we discovered top 2 universities and scientific research institutions by total patent application.
University of Minnesota
Minnesota, United States
Patent: 7
Northeast Agricultural University
Heilongjiang Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: